CX3CL1 is known to be upregulated in chronic liver disease and HCC [71,72,73,74,75]; surprisingly, high CX3CL1 levels in liver cirrhosis and HCC correlated with better patient prognosis [71,75]. Here, CX3CL1 is linked to hepatocellular carcinoma.